Medipix chips work like a camera -- they identify individual sub-atomic particles that make contact with pixels while the electronic shutter is open. According to Professor Phil Butler, one of two MARS Bioimaging Ltd scientists who built the scanner, the Medipix3 chip is what could give them an advantage in medical diagnosis: "Its small pixels and accurate energy resolution mean that this new imaging tool is able to get images that no other imaging tool can achieve".
By combining the chip's spectroscopic information with algorithms, the MARS scientists were able to create 3D color images that can distinguish clearly between fat, water and disease markers. A smaller version of the 3D scanner that's been used for studying cancer and vascular diseases is already yielding promising results, and thanks to the licensing agreement between CERN and MARS, the technology will be commercialized.
The scanner will be used in world first clinical trials involving Rheumatology and orthopedic patients in forthcoming months.